Instil Bio, Inc. financial data

Symbol
TIL on Nasdaq
Location
Dallas, TX
Fiscal year end
31 December
Latest financial report
10-Q - Q3 2025 - 13 Nov 2025

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 2155% % 50%
Debt-to-equity 67% % 35%
Return On Equity -53% % -42%
Return On Assets -32% % -27%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 6,781,976 shares 3.9%
Common Stock, Shares, Outstanding 6,781,976 shares 3.9%
Entity Public Float $38,600,000 USD 12%
Common Stock, Value, Issued $0 USD
Weighted Average Number of Shares Outstanding, Basic 6,757,742 shares 3.9%
Weighted Average Number of Shares Outstanding, Diluted 6,757,742 shares 3.9%

Income Statement

Label TTM Value / Value Unit Change %
Research and Development Expense $20,652,000 USD -77%
General and Administrative Expense $31,534,000 USD -29%
Operating Income (Loss) $80,844,000 USD -8.2%
Nonoperating Income (Expense) $929,000 USD 48%
Net Income (Loss) Attributable to Parent $75,076,000 USD 0.12%
Earnings Per Share, Basic -11 USD/shares 1.5%
Earnings Per Share, Diluted -11 USD/shares 1.5%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value $5,801,000 USD -13%
Other Assets, Current $164,000 USD -92%
Assets, Current $196,264,000 USD 48%
Property, Plant and Equipment, Net $138,000,000 USD 6%
Operating Lease, Right-of-Use Asset $415,000 USD -62%
Other Assets, Noncurrent $4,147,000 USD -33%
Assets $211,768,000 USD -22%
Accounts Payable, Current $928,000 USD -22%
Employee-related Liabilities, Current $2,085,000 USD -13%
Liabilities, Current $5,697,000 USD -45%
Operating Lease, Liability, Noncurrent $0 USD -100%
Other Liabilities, Noncurrent $88,000 USD 1000%
Liabilities $91,346,000 USD -5.1%
Accumulated Other Comprehensive Income (Loss), Net of Tax $612,000 USD -18%
Retained Earnings (Accumulated Deficit) $718,297,000 USD -12%
Stockholders' Equity Attributable to Parent $120,422,000 USD -32%
Liabilities and Equity $211,768,000 USD -22%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities $4,195,000 USD 71%
Net Cash Provided by (Used in) Financing Activities $232,000 USD
Net Cash Provided by (Used in) Investing Activities $9,611,000 USD 4%
Common Stock, Shares Authorized 300,000,000 shares 0%
Common Stock, Shares, Issued 6,781,976 shares 3.9%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $6,081,000 USD -8.7%
Interest Paid, Excluding Capitalized Interest, Operating Activities $886,000 USD -49%
Deferred Tax Assets, Valuation Allowance $141,367,000 USD 12%
Deferred Tax Assets, Gross $142,557,000 USD 13%
Operating Lease, Liability $305,000 USD -90%
Depreciation $1,210,000 USD -69%
Payments to Acquire Property, Plant, and Equipment $0 USD -100%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent $75,168,000 USD -0.01%
Lessee, Operating Lease, Liability, to be Paid $315,000 USD -91%
Property, Plant and Equipment, Gross $509,000 USD -100%
Operating Lease, Liability, Current $305,000 USD -83%
Lessee, Operating Lease, Liability, to be Paid, Year Two $1,219,000 USD -39%
Lessee, Operating Lease, Liability, to be Paid, Year One $170,000 USD -89%
Operating Lease, Weighted Average Discount Rate, Percent 0.07 pure 0%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount $10,000 USD -97%
Deferred Tax Assets, Operating Loss Carryforwards $95,773,000 USD 8.3%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 10,000,000 shares 0%
Unrecognized Tax Benefits $2,339,000 USD 0%
Operating Lease, Payments $1,603,000 USD -29%
Additional Paid in Capital $839,331,000 USD 2.3%
Preferred Stock, Shares Outstanding 0 shares
Depreciation, Depletion and Amortization $498,000 USD -50%
Deferred Tax Assets, Net of Valuation Allowance $1,190,000 USD
Share-based Payment Arrangement, Expense $11,588,000 USD -33%
Interest Expense $6,554,000 USD 160%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%